EGCG inhibited tumor growth by activating VEGF/VEGFR axis, interrupting the HIF-1a expression and other foremost growth factors, inactivation of PAR2-AP, ERK1/2, and NF-κB pathways were blocked (Zhou et al., 2012). This evidence concerns the gene VEGFA and neoplasm.